Coronary Stent Medicare Claims Review Included In HHS OIG 2004 Work Plan
This article was originally published in The Gray Sheet
Executive Summary
Inpatient and outpatient Medicare claims involving arterial stent placement will be reviewed by OIG to evaluate whether the devices are being used only when medically necessary, the agency says
You may also be interested in...
Power Wheelchairs Targeted For Inherent Reasonableness Price Adjustments
CMS plans to develop inherent reasonableness review guidelines to ensure appropriate Medicare payments for motorized wheelchairs as part of a larger initiative to curb provider billing fraud, the agency says
Drug-Eluting Stent DRGs Sustained At FY 2003 Rates – IPPS Final Rule
CMS will maintain the current DRG weights for drug-eluting stents in FY 2004, contending it is not "appropriate" to use anticipated Oct. 1 charges to set payment rates, according to the hospital 1IPPS final rule
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”